COVID-19 vaccine: Four years later, the list of persistent symptoms grows.
A study of over 99 million people (7/10)
The study was conducted by the Global Vaccine Data Network on over 99 million people. The project focused on eight countries (Argentina, Australia, Canada, France, Denmark, Finland, New Zealand, and Scotland), and the results were published in the journal Vaccine .
